The Real R&D and Clinical Benchmarks of PL3D
Rather than being the largest research project globally, the INTERmedic PL3D system has established several important milestones and distinctions within the field of medical laser technology and minimally invasive spine treatment.
World First Clinical Validation (2001)
INTERmedic developed the PL3D laser system in collaboration with the Traumatology Service at the University of Florence. This partnership resulted in the world's first published clinical data validating the use of the 980 nm diode laser wavelength for spinal disc decompression.
Extensive Clinical Experience
The principles of laser disc decompression have been evaluated through extensive clinical research, including multicenter international studies involving more than 12,500 patients. The PL3D technique itself has been used in over 100,000 procedures worldwide, making it one of the most extensively utilized laser disc decompression technologies available.
Patented Technological Innovation
A key advancement behind the PL3D system was the development of a globally patented gas and smoke evacuation system integrated directly into the surgical handpiece. This innovation addressed one of the major limitations of conventional laser disc procedures by improving procedural safety and efficiency.
One of the Largest Published PL3D Patient Cohorts
One of the largest published studies on PL3D evaluated 708 patients who underwent a total of 842 procedures, reporting a 91% clinical success rate after an average follow-up period of 21 months.
Clinical Study Overview
Purpose
To evaluate the effectiveness of Percutaneous Laser Diode Disc Decompression (PL3D) in the treatment of lumbosacral disc herniation.
Methods and Materials
Between September 2002 and February 2006, a total of 842 PL3D procedures were performed on 708 patients ranging from 16 to 84 years of age, with a mean age of 42 years. All patients experienced symptoms that were resistant to conservative medical treatment.
Procedural guidance included:
- Fluoroscopy: 553 patients
- CT Guidance: 143 patients
- Combined Fluoroscopy and CT Guidance: 12 patients
Treatment levels included:
- L2-L3: 45 cases
- L3-L4: 96 cases
- L4-L5: 395 cases
- L5-S1: 306 cases
Additionally, 48 procedures were performed on patients who had experienced unsuccessful prior microsurgery. All procedures utilized a 21G Chiba needle and a 980 nm multi-diode laser system.
Results
After a mean follow-up period of 21 months:
- 618 patients (91%) achieved a good clinical outcome according to MacNab criteria.
- Only minor complications were reported in 21 patients:
- 5 cases of aseptic spondylitis
- 16 cases of headache related to cerebrospinal fluid leakage
Conclusion
Percutaneous disc decompression using a 980 nm multi-diode laser delivered through a 21G needle under CT or fluoroscopic guidance demonstrated high effectiveness and an exceptionally low complication profile for the treatment of herniated intervertebral discs.
Clinical Relevance
PL3D provides an effective minimally invasive alternative for patients suffering from herniated discs. Published clinical data demonstrate:
- More than 100,000 procedures performed worldwide
- Reported success rates ranging from 80% to 91%
- Complication rates of less than 1%
- Outpatient treatment with minimal tissue disruption
- Rapid recovery compared with conventional surgical approaches
These outcomes support PL3D as a reliable and clinically validated option for the treatment of symptomatic disc herniation in appropriately selected patients.
Key References
- Pain Physician Journal – Clinical Outcomes of PL3D
https://www.painphysicianjournal.com/current/pdf/MTg4Mg==/74
- Percutaneous Laser Diode Disc Decompression (PL3D) with Fluoroscopic Guidance, CT Guidance and Fluoro-CT Guidance
https://www.researchgate.net/publication/266124925_Percutaneous_Laser_Diode_Disc_Decompression_PL3D_with_Fluoroscopic_Guidance_CT_Guidance_and_Fluoro-CT_Guidance